Universities Receive $100 Million for Biomedical Research

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 7 No 3
Volume 7
Issue 3

LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.

 LOS ANGELES--California businessman Alfred E. Mann has donated $100 million each to the University of Southern California (USC) and the University of California at Los Angeles (UCLA) to set up institutes for biomedical research.

At USC, the Alfred E. Mann Institute for Biomedical Engineering will be based on the University’s campus in a building that will also house the Department of Biomedical Engineering. USC president Dr. Steven Sample said that the institute would serve as a bridge between the university and the biomedical industry. Mr. Mann said he hopes the new institutes will encourage development of biotechnology companies in the Los Angeles area.

The gift to UCLA is one of the largest donations ever to a public university. The agreement for the UCLA institute is still being developed.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Breast oncologist Jade E. Jones, MD, says she tries to send patients with BRCA-mutant HR-positive TNBC to clinical trials that use PARP inhibitors.
According to Benjamin Golas, MD, PIPAC is emerging as minimally invasive laparoscopic approach for patients with peritoneal carcinomatosis.
2 experts in this video
Following progression on a CDK4/6 inhibitor, ascertaining the endocrine sensitivity of HR-positive/HER2-negative disease may inform sequential treatment.
2 experts in this video
T-DXd improved progression-free survival over standard chemotherapy among patients with HR-positive/triple-negative breast cancer in DESTINY-Breast04.
Related Content